Surgical treatment of patients (pts) with gastrointestinal stromal tumors (GIST) after imatinib mesylate (IM) therapy.

被引：0
|
作者：
Rutkowski, P
Nowecki, Z
Nyckowski, P
Dziewirski, W
Nasierowska-Guttmejer, A
Grzesiakowska, U
Michej, W
Krawczyk, M
Ruka, W
机构：
[1] Inst Warsaw, Ctr Canc, Warsaw, Poland
[2] Med Univ Warsaw, Warsaw, Poland
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2005年 / 23卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：825S / 825S
页数：1
相关论文
共 50 条
  • [1] Preoperative imatinib mesylate (IM) for huge gastrointestinal stromal tumors (GIST)
    Sumin Tang
    Yuan Yin
    Chaoyong Shen
    Jiaju Chen
    Xiaonan Yin
    Bo Zhang
    Yuqin Yao
    Jinliang Yang
    Zhixin Chen
    World Journal of Surgical Oncology, 15
  • [2] Preoperative imatinib mesylate (IM) for huge gastrointestinal stromal tumors (GIST)
    Tang, Sumin
    Yin, Yuan
    Shen, Chaoyong
    Chen, Jiaju
    Yin, Xiaonan
    Zhang, Bo
    Yao, Yuqin
    Yang, Jinliang
    Chen, Zhixin
    WORLD JOURNAL OF SURGICAL ONCOLOGY, 2017, 15
  • [3] Surgical treatment of patients with initially inoperable and/or metastatic gastrointestinal stromal tumors (GIST) during therapy with imatinib mesylate
    Rutkowski, P
    Nowecki, Z
    Nyckowski, P
    Dziewirski, W
    Grzesiakowska, U
    Nasierowska-Guttmejer, A
    Krawczyk, M
    Ruka, W
    JOURNAL OF SURGICAL ONCOLOGY, 2006, 93 (04) : 304 - 311
  • [4] Surgical Management in Metastatic Gastrointestinal Stromal Tumor (GIST) Patients After Imatinib Mesylate Treatment
    Yeh, Chun-Nan
    Chen, Tsung-Wen
    Tseng, Jeng-Hwei
    Liu, Yu-Yin
    Wang, Shang-Yu
    Tsai, Chun-Yi
    Chiang, Kun-Chun
    Hwang, Tsann-Long
    Jan, Yi-Yin
    Chen, Miin-Fu
    JOURNAL OF SURGICAL ONCOLOGY, 2010, 102 (06) : 599 - 603
  • [5] Imatinib mesylate (IM) therapy in elderly patients affected by advanced gastrointestinal stromal tumor (GIST)
    D'Ambrosio, L.
    Ponzetti, A.
    Lista, P.
    Bombaci, S.
    Palesandro, E.
    Galizia, D.
    Aliberti, S.
    Allione, P.
    Manca, A.
    Gallo, S.
    Grignani, G.
    Aglietta, M.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [6] Effects of cessation of imatinib mesylate (IM) therapy in patients (pts) with IM-refractory gastrointestinal stromal tumors (GIST) as visualized by FDG-PET scanning.
    Van den Abbeele, AD
    Badawi, RD
    Manola, J
    Morgan, JA
    Desai, J
    Kazanovicz, A
    St Armand, M
    Baum, C
    Demetri, GD
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 198S - 198S
  • [7] Necrotizing granulomatous disease in patients receiving imatinib mesylate treatment for gastrointestinal stromal tumors (GIST)
    Brueckl, V
    Agaimy, A.
    Ullrich, E.
    Krieg, S.
    Stegmann, A.
    Mackensen, A.
    Meidenbauer, N.
    ONKOLOGIE, 2011, 34 : 252 - 252
  • [8] Necrotizing granulomatous disease in patients receiving imatinib mesylate treatment for gastrointestinal stromal tumors (GIST)
    Meidenbauer, N.
    Stegmann, A.
    Mackensen, A.
    Agaimy, A.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [9] Survival benefit of imatinib mesylate on patients with advanced gastrointestinal stromal tumors (GIST)
    Lin, M. T.
    Hu, T. H.
    Lin, J. W.
    Wang, C. C.
    Rau, K. M.
    Changchien, C. S.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2009, 24 : A44 - A44
  • [10] Patterns of PET response after long-term sunitinib therapy in patients (pts) with imatinib (IM)-resistant gastrointestinal stromal tumors (GIST).
    Raut, C. P.
    Van Den Abbeele, A.
    Ramaiya, N.
    Morgan, J. A.
    George, S.
    Quigley, M. T.
    Dollard, A. M.
    Bertagnolli, M. M.
    Baum, C.
    Demetri, G. D.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 531S - 531S
12345